Skip to content

Effectiveness of a Cervical Cancer Stigma Reduction Intervention Program on Cancer Stigma Score and Cervical Cancer Screening Uptake in Nepal

Effectiveness of a Cervical Cancer Stigma Reduction Intervention Program on Cancer Stigma Score and Cervical Cancer Screening Uptake in Nepal

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05489978
Enrollment
310
Registered
2022-08-05
Start date
2022-06-15
Completion date
2023-02-15
Last updated
2026-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Cancer, Screening, Stigma

Brief summary

It is an interventional study to assess the effectiveness of the cervical cancer stigma reduction intervention on cancer stigma score and cervical cancer screening uptake in Nepal

Detailed description

Despite the presence of ample evidence, that stigma is one of the major reasons for low screening coverage, Nepal does not have a single stigma reduction intervention targeted among women to increase cervical cancer screening coverage. Therefore, we aim to assess the effectiveness of a stigma reduction education program on stigma score and cervical cancer screening uptake in Nepal. We will conduct an interventional study in Budanilkhantha Municipality. A computer-based program will randomly allocate the 12 wards of Budanilkhantha Municipality with an allocation ratio 1:1; 6 wards in intervention group and 6 wards in control group. We will conduct a "stigma reduction education program" in the intervention group. After that we will follow up the participants for 2 months to see the effectiveness of a stigma reduction education program on stigma score and cervical cancer screening uptake in Nepal. We will analyze data using STATA 14. We will use independent tests to find the mean difference between cervical cancer screening uptake and cervical cancer stigma score. The difference in mean among the two groups will actually be the difference due to intervention given. Findings from this study will help managers and stakeholders to formulate and improve strategies on screening programs and develop programs to reduce stigma on cervical cancer among women in Nepal.

Interventions

BEHAVIORAL"Cervical Cancer Stigma Reduction Intervention"

Change in knowledge: Cervical cancer burden in Nepal, signs and symptoms, preventive measures available, lifestyle modifications, HPV vaccination, early diagnosis, screening, and treatment. Change in Stigma 1. Para-social contact * Video of a person facing cervical cancer what symptoms she got, how she dealt with it, and how she overcame it. * Experiences of a cervical cancer survivor so that women personalize the information by relating it to their own life experiences by changing their attitude and behavior. 2. Participatory learning techniques * Personal stories: Voluntary self-reflection of any stigma they perceive on cervical cancer or their community perceives cervical cancer. * Group Discussion: Discuss the drivers of stigma, facilitators of sigma, types of stigma prevalent in your community, and consequences of stigma. 3. Myths vs facts: Negative attitudes, myths, and misconceptions about cervical cancer will be contraindicated by factual information.

Sponsors

Kathmandu University School of Medical Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
30 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Women aged 30-60 years (the age range recommended for VIA screening in Nepal * Married women * Residents of Budanilkantha Municipality

Exclusion criteria

* Women who have already undergone screening within 5 years. * Women with hearing or mental disorders * Pregnant women * Less than 6 weeks postpartum * Mothers who had lived in the community for less than 6 months to perform seasonal work (e.g. in brick kilns) or visitors in the family. * Women who are already diagnosed with cervical pre-cancer and cancer and have undergone hysterectomy.

Design outcomes

Primary

MeasureTime frameDescription
Mean stigma scoreMeasured at baseline and endline (after 2 months gap from baseline)Change in mean stigma score using Cancer Stigma Scale at baseline and follow up

Secondary

MeasureTime frameDescription
Cervical cancer screening uptakeMeasured within a month after endlineNumber of women attending cervical cancer screening program in intervention and control groups

Countries

Nepal

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 16, 2026